From 6ebf1f1858590b53b47f67708cbd79aa57f79a67 Mon Sep 17 00:00:00 2001 From: YurenHao0426 Date: Thu, 23 Jul 2026 08:24:43 -0500 Subject: paper: integrate calibrated oral-B-v2 evidence --- ROADMAP.md | 25 +++++++++++++++++++++++++ 1 file changed, 25 insertions(+) (limited to 'ROADMAP.md') diff --git a/ROADMAP.md b/ROADMAP.md index c40efc5..39b78f5 100644 --- a/ROADMAP.md +++ b/ROADMAP.md @@ -55,6 +55,31 @@ outcome accuracy is only `47.33%`, residuals trail soma outcome decoding by oral-A stays sealed, and no threshold repair or replacement confirmation is permitted. Because `kappa=0`, neither R1 nor R2 could support online control. +**Oral-B-v2 development path: two failures retained.** `ORAL_B_V2.md` adds an +explicit terminal reward/timeout phase, a local TD critic, and eligibility +traces without changing the old R2. Its complete 24-record development grid +fails from a cold start: the dense performance innovation was scaled to +one-quarter of the validated rule and no candidate learns. A separately frozen +unit-scale recovery restores 100% task performance and passes every mechanism +gate on task seeds 23 and 24; task seed 25 passes 17/18 gates but succeeds on +98.96% of a fixed absolute target ladder. That class-balance failure is also +retained and does not open confirmation. + +**Oral-B-v2 calibrated R1/R2 status: passed.** The final branch changes no +learning parameter. Five target levels are fixed by cursor-maximum quantiles +on 512 separate outcome-free calibration trials, then evaluated on independent +trajectories. Fresh development seeds 26--28 pass all 18/18 checks. The +untouched 6-task by 5-model confirmation then passes every learning, +innovation, network-prediction, outcome, lesion, and task-cluster confidence +gate: final success is `100%`, learning gain `98.80` points, fixed-role gap +`99.97` points, role cosine `0.9761`, residual--soma correlation `0.0631`, +surrounding accuracy `54.37%` (lower bound `54.26%`), velocity advantage +`0.6384`, terminal outcome accuracy `99.83%` (lower bound `99.68%`), acute +outcome-lesion separation drop `0.4000` (lower bound `0.3886`), critic +expectedness `0.3187` (lower bound `0.2814`), and 30/30 positive signs. The +formal milestone rises from 7 to 8. The old oral-A gate remains closed; only a +new independently frozen oral-A-v2 protocol may now run. + ## Frozen accept claims and gates ### C1. Innovation is necessary under naturally mixed apical traffic -- cgit v1.2.3